Jacob Albersheim

Papers

Total Citations

H-Index

About

Dr. Jacob Albersheim is a urologic surgeon and researcher whose work centers on improving surgical outcomes for patients with bladder cancer, particularly through enhanced recovery pathways. His most-cited study, “Alvimopan as part of the Enhanced Recovery After Surgery protocol following radical cystectomy is associated with decreased hospital stay” (2021), has garnered 8 citations and represents a significant contribution to perioperative care. In this retrospective analysis of 296 patients, Dr. Albersheim demonstrated that combining alvimopan with an Enhanced Recovery After Surgery (ERAS) protocol significantly reduces length of hospital stay after radical cystectomy—a major, high-morbidity procedure. This work has helped establish evidence-based protocols that accelerate recovery, reduce complications, and improve patient experience. By integrating pharmacologic and multimodal recovery strategies, Dr. Albersheim’s research directly addresses one of urologic oncology’s most pressing challenges: optimizing postoperative outcomes while maintaining safety. His findings have informed clinical practice at his institution and beyond, offering a practical framework for surgeons seeking to enhance recovery in complex cancer surgery. Dr. Albersheim’s contributions exemplify how rigorous clinical research can translate into tangible improvements in patient care.